Pay in 4 interest-free payments of $29.38 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Cephalosporin C sodium is used to study the effect of transpeptidase expression
mutation of Trp741 to Cys)
PubMed PMID: 25374341
((2-((5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl)amino)pyridin-4-yl)methyl)(imino)(methyl)-l6-sulfanone
4-dihydroxyphenyl)prop-2-enoate
GV-58 60427 Cephalosporin C sodium is usedGV 58 is a potent, selective N and P Q type Ca2+ channels agonist with EC50 of 7. 21 8. 81 uM for N type P Q type Ca2+ channel; 20 fold less potent CDK inhibitor activity. IC50 value: 7. 21 8. 81 uM (N type P Q type Ca2+ channel) Target: Ca2+ channel agonistIn comparison with the parent molecule, (R) roscovitine, GV 58 has a 20 fold less potent cyclin dependent kinase antagonist effect, a 3 to 4 fold more potent Ca2+ channel agonist effect, and 4 fold
US$ 276.77
US$ 3193.47
US$ 154.47
US$ 159.16